SGEM#184: We Weren’t Born to Follow-Up – The PEITHO Long-Term Follow-up Study

Trials extracted from the podcast by Dr. Ken Milne

• 2017PEITHOAnticoagulation & AntithromboticsIn709 normotensive patients with intermediate-risk pulmonary embolism,tenecteplasedid not lowerlong-term mortalitycompared withplacebo
• 2014PEITHOAnticoagulation & AntithromboticsIn 1006 patients with intermediate-risk pulmonary embolism, tenecteplase reduced death or haemodynamic decompensation at 7 days compared with placebo